R. A. Chandraratna

发表

The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.

P. Elias, G. Krueger, G. Weinstein, 1998, Archives of dermatology.

Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.

A. Shalita, E. Tschen, D. Chalker, 1999, Cutis.

New dermatological agents for the treatment of psoriasis.

S. Nagpal, S. Thacher, K. Tsang, 2001, Journal of medicinal chemistry.

Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.

M. Lebwohl, J. Callen, T. Phillips, 1998, Journal of the American Academy of Dermatology.

Novel approaches for the treatment of psoriasis.

D. Disepio, S. Nagpal, DiSepio, 1999, Drug discovery today.

Molecular mechanisms of tazarotene action in psoriasis.

S. Nagpal, M. Duvic, A. Asano, 1997, Journal of the American Academy of Dermatology.

Response of psoriasis to a new topical retinoid, AGN 190168.

M. Duvic, J. Sefton, R. Chandraratna, 1994, Journal of the American Academy of Dermatology.

Therapeutic applications for ligands of retinoid receptors.

R. Chandraratna, S. Thacher, J. Vasudevan, 2000, Current pharmaceutical design.

Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene.

R. Eckert, A. Deucher, D. Disepio, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin.

H. Jacobe, D. Disepio, S. Nagpal, 1997, The Journal of investigative dermatology.

Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma

S. Friant, S. Nagpal, R. Chandraratna, 1997, Molecular and cellular biology.

Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.

R. A. Chandraratna, 1997, Journal of the American Academy of Dermatology.

Retinoic acid receptor-β: an endogenous inhibitor of the perinatal formation of pulmonary alveoli

N. Ghyselinck, G. Massaro, L. Clerch, 2000 .

Multiple left-right asymmetry defects in Shh(-/-) mutant mice unveil a convergence of the shh and retinoic acid pathways in the control of Lefty-1.

Concepción Rodríguez-Esteban, R. Evans, B. Blumberg, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Requirement for RAR-mediated gene repression in skeletal progenitor differentiation

J. Torchia, T. Underhill, R. Chandraratna, 2002, The Journal of cell biology.

Rational design of receptor-selective retinoids.

R. Chandraratna, R. A. Chandraratna, 1998, Journal of the American Academy of Dermatology.

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.

E. Fleck, W. Hsueh, S. Wakino, 2000, European journal of pharmacology.

Overlapping Transcriptional Programs Regulated by the Nuclear Receptors Peroxisome Proliferator-Activated Receptor α, Retinoid X Receptor, and Liver X Receptor in Mouse Livers⃞

J. Corton, J. Gustafsson, C. Swanson, 2004, Molecular Pharmacology.

Retinoic acid receptor signalling directly regulates osteoblast and adipocyte differentiation from mesenchymal progenitor cells

T. Martin, M. Walia, R. Chandraratna, 2017, Experimental cell research.

Regulation of Stearoyl Coenzyme A Desaturase Expression in Human Retinal Pigment Epithelial Cells by Retinoic Acid*

J. Gordon, R. Chandraratna, W. Samuel, 2001, The Journal of Biological Chemistry.

Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.

R. Chandraratna, S. Thacher, V. Vuligonda, 2001, Journal of medicinal chemistry.

Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells.

R. Lotan, W. Hong, R. Lotan, 2000, Molecular pharmacology.

Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect.

G. Krueger, G. Weinstein, M. Duvic, 1997, Journal of the American Academy of Dermatology.

Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.

R. Eckert, E. Rorke, S. Nagpal, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Specific antagonist of retinoid toxicity in mice.

M. Escobar, R A Chandraratna, A M Standeven, 1996, Toxicology and applied pharmacology.

Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin.

S. Nagpal, M. Duvic, A. Johnson, 1996, The Journal of investigative dermatology.

Retinoid-induced epiphyseal plate closure in guinea pigs.

V. Thomazy, R. Chandraratna, P. Davies, 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Overlapping Transcriptional Programs Regulated by the Nuclear Receptors Peroxisome Proliferator-Activated Receptor (cid:1) , Retinoid X Receptor, and Liver X Receptor in Mouse Liver □ S

J. Corton, T. Stulnig, K. Steffensen, 2004 .

Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors.

M. Boehm, R. Heyman, R. Chandraratna, 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.